UK Markets close in 6 hrs 34 mins

BlackRock Health Sciences Trust (BME)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
47.97+0.12 (+0.25%)
At close: 3:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5573.52M
Enterprise value 3593.26M
Trailing P/E 7.21
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)109.42
Price/book (mrq)1.05
Enterprise value/revenue 3113.18
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 350.94
52-week low 340.03
50-day moving average 347.63
200-day moving average 347.52

Share statistics

Avg vol (3-month) 329.97k
Avg vol (10-day) 328.02k
Shares outstanding 511.96M
Implied shares outstanding 6N/A
Float N/A
% held by insiders 14.72%
% held by institutions 114.90%
Shares short (14 Apr 2021) 411.06k
Short ratio (14 Apr 2021) 40.32
Short % of float (14 Apr 2021) 40.09%
Short % of shares outstanding (14 Apr 2021) 40.09%
Shares short (prior month 14 Mar 2021) 48.39k

Dividends & splits

Forward annual dividend rate 42.4
Forward annual dividend yield 44.84%
Trailing annual dividend rate 32.40
Trailing annual dividend yield 35.02%
5-year average dividend yield 46.25
Payout ratio 434.93%
Dividend date 330 Jan 2019
Ex-dividend date 413 Apr 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 1,517.89%
Operating margin (ttm)1.31%

Management effectiveness

Return on assets (ttm)0.01%
Return on equity (ttm)16.03%

Income statement

Revenue (ttm)5.24M
Revenue per share (ttm)0.44
Quarterly revenue growth (yoy)4.40%
Gross profit (ttm)5.24M
EBITDA N/A
Net income avi to common (ttm)79.56M
Diluted EPS (ttm)6.66
Quarterly earnings growth (yoy)55.50%

Balance sheet

Total cash (mrq)211.7k
Total cash per share (mrq)0.02
Total debt (mrq)102.7k
Total debt/equity (mrq)0.02
Current ratio (mrq)0.15
Book value per share (mrq)45.66

Cash flow statement

Operating cash flow (ttm)-19.35M
Levered free cash flow (ttm)2.04M